Role of activation of the coagulation system in the pathogenesis of urticaria

Affiliations

¹ Department of Immunology, Mie University Faculty and Graduate School of Medicine, and Mie University Hospital, Tsu, Japan.
² Department of Pulmonary and Critical Care Medicine, Mie University Faculty and Graduate School of Medicine, and Mie University Hospital, Tsu, Japan.
³ Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.

Comment

Taro Yasuma et al. Allergy. 2021 Oct.

. 2021 Oct;76(10):3243-3244.

doi: 10.1111/all.15015.

¹ Department of Immunology, Mie University Faculty and Graduate School of Medicine, and Mie University Hospital, Tsu, Japan.
² Department of Pulmonary and Critical Care Medicine, Mie University Faculty and Graduate School of Medicine, and Mie University Hospital, Tsu, Japan.
³ Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.

No abstract available

Comment on

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review.
Mostmans Y, De Smedt K, Richert B, Elieh Ali Komi D, Maurer M, Michel O. Mostmans Y, et al. Allergy. 2021 Oct;76(10):2998-3016. doi: 10.1111/all.14828. Epub 2021 Apr 25. Allergy. 2021. PMID: 33768540

1. Mostmans Y, De Smedt K, Richert B, Elieh Ali Komi D, Maurer M, Michel O. Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: a systematic review. Allergy. 2021. https://doi.org/10.1111/all.14828. Online ahead of print.
1. Takeda T, Sakurai Y, Takahagi S, et al. Increase of coagulation potential in chronic spontaneous urticaria. Allergy. 2011;66:428-433.
1. Zhu H, Liang B, Li R, et al. Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol. 2013;31:43-50.
1. Takahagi S, Mihara S, Iwamoto K, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. 2010;65:649-656.
1. Asero R, Marzano AV, Ferrucci S, Cugno M. Elevated baseline D-dimer plasma levels are associated with a prompt response to omalizumab in patients with severe CSU. J Allergy Clin Immunol Pract. 2017;5:1740-1742.